Home > Journals > China Journal of Chinese Materia Medica >Issue 19,2019
China Journal of Chinese Materia Medica
Translated from the Chinese edition
Supervisor(s): China Association for Science and Technology
Sponsor(s): Institute of Chinese Pharmaceutical Association
CN:11-2272/R

24 issues per year

Current Issue: Issue 19, 2019  

Total Downloads:80

Journal official website:http://zgzye.cbpt.cnki.net/WKE/WebPublication/index.aspx?mid=zgzye

  • China Journal of Chinese Materia Medica, the 1st in the field of TCM, is supervised by China Association for Science and Technology and sponsored by Institute of Chinese Pharmaceutical Association. The journal is China's earliest comprehensive core journal of traditional Chinese medicine, and always maintains the circulation top in the professional areas. The journal publishes the latest research and progress of traditional Chinese medicine and takes a leading position in numbers of articles published, downloads and citations among all journals in this discipline. Its scope covers new achievements, technologies, methods, experiences and concepts resulting from the research on Chinese materia medica pursuant to Chinese medical and pharmaceutical theories, traditional experiences, and modern science and technology, including medicinal resources and identification, cultivation, processing, preparation, chemistry, pharmacology, theory of Chinese pharmacy and clinical practice, bencaological study. The journal is included in CA, JST and CSCD.

  • Honorary Editor-in-Chief
    Xiao Peigen
    Editor-in-Chief
    Wang Yongyan

    Associate Editors
    Zhang Boli, Hu Zhibi, Yao Xinsheng, Li Lianda, Li Dapeng, Yang Baofeng, Zhou Chaofan, Huang Luqi, Chen Shilin, Li He.

    Executive Editorial Board
    Cai Shaoqing, Chen Shilin

Preparation of angiopep-2-modified FITC-labeled neurotoxin nanoparticles and in vitro release characteristics

LI Wu-chao;YAN Li-li;CHEN Xiao-jie;LI Fan-zhu;ZHU Zhi-hong

China Journal of Chinese Materia Medica,2019,Vol 44,No. 19

7-hydroxy sulfonation of liquiritigenin by recombinant SULT1A3 enzyme and HEK-SULT1A3 cells

ZHANG Yi-dan;LI Hai-ying;LIU Fan-ye;NIU Jie;WANG Xiao;LIANG Chao;SUN Hua

China Journal of Chinese Materia Medica,2019,Vol 44,No. 19

Mechanism of different processed products of Codonopsis pilosula on spleen deficiency rats based on 1H-NMR metabonomics

HAO Yan-yan;HE Pan;NIE Chun-xia;WU Xiao-wei;LIU Cong;HAO Xu-liang

China Journal of Chinese Materia Medica,2019,Vol 44,No. 19

Pharmacokinetics of four phenolic acids from Danshen–Chuanxiong drug pair in plasma and heart tissue of rats by UPLC-MS/MS

ZHANG Cui-ying;ZHANG Hong;REN Wei-guang;DONG Yu

China Journal of Chinese Materia Medica,2019,Vol 44,No. 19

Study on preventive and therapeutic effects of Erzhi Pills on mice with Parkinson’s disease induced by MPTP

WU Xin-fang;DUAN Leng-xin;GAO Xiao-le;GUO Man-lin;WANG Dong-mei

China Journal of Chinese Materia Medica,2019,Vol 44,No. 19

Application of Chinese medicine quality constant in grade evaluation of Moutan Cortex

YAN Mei;SHI Jia;SHEN Li;XU Fei-la;PAN Chun-yan;LI Gong-hui;JING Wen-guang;DENG Zhe

China Journal of Chinese Materia Medica,2019,Vol 44,No. 19

Marker Genes of Geniposide-induced Hepatotoxicity based on Genomic Strategy

HU Yan-zhen;LI De-feng;ZHANG Yi;WEI Jun-ying;YANG Hong-jun

China Journal of Chinese Materia Medica,2019,Vol 44,No. 19